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Background: The importance of utilising the best available research evidence in the development of health policies,
services, and programs is increasingly recognised, yet few standardised systems for quantifying policymakers’ research
use are available. We developed a comprehensive measurement and scoring tool that assesses four domains of
research use (i.e. instrumental, conceptual, tactical, and imposed). The scoring tool breaks down each domain into its
key subactions like a checklist. Our aim was to develop a tool that assigned appropriate scores to each subaction based
on its relative importance to undertaking evidence-informed health policymaking. In order to establish the relative
importance of each research use subaction and generate this scoring system, we conducted conjoint analysis with a
sample of knowledge translation experts.
Methods: Fifty-four experts were recruited to undertake four choice surveys. Respondents were shown combinations
of research use subactions called profiles, and rated on a 1 to 9 scale whether each profile represented a limited (1–3),
moderate (4–6), or extensive (7–9) example of research use. Generalised Estimating Equations were used to analyse
respondents’ choice data, which calculated a utility coefficient for each subaction. A large utility coefficient indicated
that a subaction was particularly influential in guiding experts’ ratings of extensive research use.
Results: Utility coefficients were calculated for each subaction, which became the points assigned to the subactions in
the scoring system. The following subactions yielded the largest utilities and were regarded as the most important
components of each research use domain: using research to directly influence the core of the policy decision; using
research to inform alternative perspectives to deal with the policy issue; using research to persuade targeted
stakeholders to support a predetermined decision; and using research because it was a mandated requirement by the
policymaker’s organisation.
Conclusions: We have generated an empirically derived and context-sensitive means of measuring and scoring the
extent to which policymakers used research to inform the development of a policy document. The scoring system can
be used by organisations to not only quantify the extent of their research use, but also to provide them with insights
into potential strategies to improve subsequent research use.
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Research is widely regarded as providing the most reli-
able evidence source upon which to base decisions relat-
ing to health policies, programs, and other courses of
action [1-5]. The process of incorporating the best avail-
able research evidence to inform decision making relat-
ing to programs and public health policies is called
evidence-informed health policymaking [6,7]. Evidence-
informed health policymaking is purported to lead to
better health policies, more effective implementation,
and more efficient use of resources, with the ultimate
goal of improving health outcomes for the wider com-
munity [8,9]. The public health literature describes nu-
merous policies that have been informed by research in
a range of health areas (e.g. smoking, alcohol use, im-
munisation, fall prevention, cardiovascular health, neural
development, and mental health [10-16]). Many of these
policies have been associated with improvements in
health, suggesting a possible link between evidence-
informed policymaking and better health outcomes. In
light of these potential benefits, policymakers and organi-
sations are showing greater appreciation of the import-
ance and usefulness of research as a source of information
to guide decision making [17].
Despite these gains, there are global calls to strengthen
the capacity of policy organisations to utilise the best
available evidence from research in healthcare practices
and policies [18]. This is because, internationally, many
opportunities to use research to inform policymaking
are missed [17,19-23], ineffective health policies which
are not supported by the available evidence continue to
be implemented (e.g. [10,24,25]), and healthcare expend-
iture continues to rise rapidly [26,27].
The importance of measuring research use in policy and
existing measures
In this context, it is essential that validated measures of
research use are developed. Such measures will greatly
assist policymaking organisations to evaluate their current
level of research use, use these findings as a start off point
to invest in resources or programs to increase their re-
search use capacity, and monitor the effectiveness of these
interventions [28]. Organisations could also use such mea-
sures to quantify the impact of research use on health out-
comes and financial expenditures. This may motivate
ongoing research use by organisational staff, promote
funding and production of policy-relevant research by
research organisations [8,9,29], and justify continued
government investment into research with real-world
impacts [30].
Despite these potential benefits, few measures of re-
search use in health policy are available [19,31-37]. The
measures that are available have some key limitations such
as a lack of a clear theoretical basis, narrow definition ofthe concept of research use, application to health care as
opposed to policy, reliance on self-report, and absence of
a valid scoring system [37]. In addition, currently available
measures do not assess research use in relation to specific
policy products that were recently developed, but instead
ask policymakers about their research use in general or
over extended periods of time (e.g. 5 years [19]). This lack
of time specificity, context, and reference to a concrete
document, may lead to difficulties with recall and inaccur-
ate reporting of research use [38,39].
Zardo and Collie [37] developed a content analysis ap-
proach to measuring research use, where individual pol-
icy documents are coded for the type of evidence cited
and how that evidence was used (i.e. to support policy
development or guide decision making). The primary
limitation with their approach is that only instrumental
use and direct references to research are assessed. Con-
sequently, their measure does not take into account
uncited research, research that contributed to ideas and
concepts surrounding the policy document’s develop-
ment (i.e. conceptual use [40]), or research that was used
to persuade stakeholders or justify predetermined deci-
sions (i.e. tactical use [41]).
SAGE: A new measure of research use
To overcome the limitations of previous measures, we
developed a comprehensive, multi-modal (i.e. interview,
document analysis), and theory-based measure of policy-
makers’ use of research in the development of a recently
approved health policy or program document, entitled
Staff Assessment of enGagement with Evidence from re-
search (SAGE). Within SAGE, research evidence refers
to analyses of quantitative or qualitative data, or theory,
found in peer-reviewed articles, books, technical mono-
graphs, or grey literature such as internally conducted
studies, evaluations, or reports on authoritative websites
[42]. SAGE was developed as part of the Centre for
Informing Policy in Health with Evidence from Research
(CIPHER), which was established with the aim of devel-
oping and testing new strategies to increase the use of
research evidence in policy, improving policymakers’ ac-
cess to information summaries, building researchers’
skills in working with policy agencies, and developing
new ways of measuring the use of research in policy.
SAGE is informed by the Supporting Policy in Health
with Research: an Intervention Trial (SPIRIT) Action
Framework, which describes the steps, barriers, facilita-
tors, and contextual influences along the pathway to
using research to inform policymaking [28]. The frame-
work provides a simplified schematic to summarise the
process through which research informs policymaking,
but in no way assumes that policymaking is a linear, pre-
dictable process [19]. Specifically, the framework de-
scribes that when policymakers seek out research to
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ber of research engagement actions (e.g. accessing, ap-
praising, and generating new research). Once relevant
research has been obtained and/or generated, it can then
be used to inform the key stages of policymaking (e.g.
agenda setting, policy development). Research is concep-
tualised as being used in four different, but non-
mutually exclusive ways. Specifically, research may (1)
provide new ideas, understanding, or concepts to clarify
thinking about the policy issue without directly influen-
cing content (conceptual use [43,44]); (2) directly influ-
ence what issues to prioritise and/or what action should
be taken to deal with the identified issue(s) (instrumental
use [19,45,46]); (3) be used to justify or lend weight to
pre-existing decisions and courses of action relating to
the issue (tactical use [41,47]); and/or (iv) be used to
meet organisational, legislative, or funding requirements
to use research (imposed [46]). The Framework predicts
that each of the four kinds of research use may lead
to more policies that are informed by research and
possibly better health services and outcomes, but only
if the most relevant and reliable research available is
used.
Informed by this framework, SAGE broadly assesses
(1) the extent to which policymakers undertook research
engagement actions, and (2) the extent to which re-
search was used to inform the development of a policy
document. SAGE consists of a comprehensive interview
and a scoring tool. In the interview, policymakers are in-
vited to describe how research was searched for, ob-
tained, appraised, generated (i.e. research engagement
actions), and used (i.e. research use: conceptual, instru-
mental, tactical, and imposed) to inform the develop-
ment of a discrete policy document (see Additional file 1
for the SAGE interview). The interview takes approxi-
mately 40 min to complete and is administered by aFigure 1 Example scoring checklist for conceptual research use.trained interviewer with experience in qualitative ana-
lysis and interviewing.
The accompanying SAGE scoring tool allows objective
assessors to rate the thoroughness with which policy-
makers undertook research engagement actions and the
extent to which research was used in the development
of the policy document. In this paper, we describe how
the tool was developed to score the research use compo-
nent of SAGE. The scoring system to assess research en-
gagement actions is described in another paper [48]. The
scoring tool is a comprehensive checklist that lists the
key subactions of the four research use domains (Figure 1
provides an example of the checklist for tactical use).
These subactions are the essential features or actions
of each research use domain (see Table 1 for defini-
tions of key terms and examples). For example, subac-
tions of tactical research use include using research to
validate a predetermined decision, or using research to
persuade stakeholders to support a decision. Using the
SAGE interview transcript and the accompanying pol-
icy document, external raters mark on the scoring tool
whether or not the policymaker undertook each of
these key subactions. Such a scoring tool is beneficial
in allowing agencies to evaluate policymakers’ current
use of research in policy development, as well as the
impact of programs designed to improve evidence-
informed health policymaking.
Developing a system to score research use
What is missing from the current scoring tool is a sys-
tem that assigns a numeric score to each subaction and
thus enables the calculation of a total score for each re-
search use domain. Assigning an identical score to each
subaction is not appropriate given that extensive qualita-
tive research indicates that certain subactions represent
stronger examples of a particular research use domain
Table 1 Definitions of key terms
Term Definition Example
Research use domains The four ways in which research can be used in policymaking
based on the literature on evidence-informed policymaking.
Throughout the paper, research use domains are numbered
with Arabic numerals.
1. Instrumental use: research directly influences what issues
to prioritise and/or what action should be taken to deal
with the identified issue(s)
2. Conceptual use: research is used to provide new ideas,
understanding, or concepts to clarify thinking about the
policy issue without directly influencing content
3. Tactical use: research is used to justify or lend weight to
pre-existing decisions and courses of action relating to the
issue
4. Imposed use: research is used to meet organisational,
legislative, or funding requirements to use research
Subactions Subactionsa are the essential features or main actions of each
research use domain. They often refer to broad, concrete
example actions of using research in each of the four
domains. Each research use domain has a number of
subactions that were identified through examination of
literature on evidence-informed policymaking and interviews
with policymakers. Subactions are numbered with letters.
Examples of subactions of tactical research use include:
a. Research is used to support, confirm, or justify established
positions or decisions relating to the issue
b. Research is used to provide hard evidence to persuade
targeted stakeholders to support an existing decision or
view
c. Research is used to provide hard evidence to persuade
peripheral stakeholders to support an existing decision or
view
d. Research is used to inform stakeholders about key issues
relating to the health issue
Level Levels in conjoint analysis refer to all the possible values of a
subaction and are often described in concrete terms. To
undertake a conjoint analysis, each subaction must be divided
into concrete, perceptible levels. In the present study, the
majority of subactions were divided into two levels (i) Yes, the
subaction was performed by the policymaker, or (ii) No, it was
not performed by the policymaker. Different levels of
subactions are combined in various combinations to form
profiles. Throughout the paper, levels are numbered using
Roman numerals.
As above, one of the subactions of tactical research use was
“using research to support, confirm, or justify established
positions or decisions relating to the issue”. This subaction
has two levels:
(i) Yes, the policymaker used research to support, confirm, or
justify an established position or decision relating to the
issue
(ii) No, the policymaker did not use research to support,
confirm, or justify an established position or decision
relating to the health issue
Profile A research use profile is made up of a combination of
subaction levels. Specifically, a profile consists of one level of
each subaction within that research use domain
Using the research use domain – tactical research use, an
example profile would be:
a. (i) Yes, research was used to support, confirm, or justify
established positions or decisions relating to the issue
b. (ii) No, research was not used to provide hard evidence to
persuade targeted stakeholders to support an existing
decision or view
c. (ii) No, research was not used to provide hard evidence to
persuade peripheral stakeholders to support an existing
decision or view
d. (i) Yes, research was used to inform stakeholders about
key issues relating to the health issue
aTo enhance clarity and comprehension throughout the paper, we used the term subaction instead of attribute, which is most commonly used in choice studies
and conjoint analysis.
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suade stakeholders to support a course of action relating
to a health issue [3,47] is a stronger form of tactical re-
search use than using research to inform stakeholders
about the issue [49]. Previous research has often in-
volved qualitative interviews with health policymakers
and researchers with varying levels of experience and se-
niority. There has been no attempt, however, to quantify
the views of policymakers and researchers regarding therelative importance of different research use subactions.
Consequently, an appropriate scoring system cannot be
generated on the basis of previous research.
Using conjoint analysis to develop a system to score
research use
One systematic method of quantifying experts’ views re-
garding the value to assign each research use subaction
is conjoint analysis [50-55]. Conjoint analysis has been
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ucts and services patients prefer, and the attributes driving
these preferences [52,53,56-59]. In traditional conjoint
analysis, respondents rate combinations of subactions1
called profiles (see Table 1 for definitions). This is an eco-
logically valid approach, because each type of research use
is composed of several smaller actions [28]. For example,
conceptual research use not only includes what knowledge
areas were improved by research, but also the extent to
which research improved this knowledge. After profiles
have been rated, conjoint analysis is used to compute nu-
meric values or utilities for each subaction. These utilities
quantify the relative importance of each subaction to each
research use domain, based on the opinions and prefer-
ences of the chosen sample. These utilities can then be
used as the score assigned to each subaction within a scor-
ing tool.
An appropriate sample for the current conjoint ana-
lysis would be individuals with extensive experience
working at the nexus between health policy and re-
search. Such experts are cognisant of the diverse ways
research can influence policy in light of political influ-
ences, stakeholder interests, skill and resource limita-
tions, and other contextual factors. Consequently, they
can provide informed and context-sensitive judgments
regarding the relative importance of each research use
subaction, which can then be used to generate appropri-
ate and context-sensitive scores for these subactions.
In summary, the aim of this paper was to use conjoint
analysis to generate a context-appropriate and valid sys-
tem to score policymakers’ research use in policy devel-
opment, based on the opinions of experts in health
policy and research. We envision that the scoring system
will help to inform policy organisations of the most im-
portant components of research use, which can then be
addressed through targeted interventions to build re-
search capacity and use in policymaking.
Method
Ethics
Ethics approval was granted by the University of Western
Sydney Human Research Ethics Committee HREC
Approval H10440. Written consent was obtained from
all potential respondents prior to their participation in
the study.
Respondents
In recruiting respondents to undertake the conjoint ana-
lysis surveys, we targeted experts working at the nexus be-
tween health policy and health research. Firstly, we
identified relevant researchers by contacting correspond-
ing authors of key research articles in the area of
evidence-informed health policymaking. Secondly, we
contacted members of the CIPHER community to identifyresearchers and policymakers with experience in both
health policy and health research. Using this method, 361
experts were invited by email to participate in the study
(making them the respondents/participants for the pur-
poses of this paper). Of the invited respondents, 267
(74%) were from Australia, 52 (14%) were from North
America (16 United States, 35 Canada, and 1 Mexico),
40 (11%) were from Europe (31 United Kingdom, 1
Austria, 1 Ireland, 1 Sweden, 3 Norway, 3 Netherlands),
and 2 (<1%) were from Africa (1 each from Mali and
Uganda).Procedure
We followed the guidelines specified by Bridges et al. [54]
and Lancsar and Louviere [60] for designing, conducting,
analysing, and reporting on the findings of choice experi-
ments. Furthermore, we applied principles of Hierarchical
Information Integration by separating research use into its
key domains (i.e. conceptual, instrumental, tactical, and
imposed), identifying key, non-overlapping subactions for
each domain, and undertaking a separate choice experi-
ment for each domain [61,62]. These steps are described
below.Defining the subactions and levels
We undertook a comprehensive, step-by-step approach
to identify the subactions of each research use domain.
We first defined each of the four research use domains
using the SPIRIT Action Framework [28], seminal re-
search on evidence-informed policymaking, and Haynes
and colleagues’ review of health policy definitions [63].
With these definitions in mind, we conducted a thorough
analysis of the (1) extant literature on evidence-informed
health policymaking, and (2) 65 SAGE interviews with
Australian health policymakers from six Australian health
organisations, to identify a broad range of concrete exam-
ples of each research use domain. Note that these inter-
viewees were not the respondents that completed the
conjoint surveys (i.e. they were not the participants in this
study).
A vast number of examples of each research use do-
main were identified from the literature (over 100) and
interviews (approximately 40). Similar examples were
then categorised into groups. Each group was given an
action label that encompassed all the examples within
that group. These action labels became the subactions
for a particular research use domain. For example, using
research to understand the current prevalence rate of a
disease and using research to understand risk factors for
a particular health condition, were both examples of
Conceptual Research Use identified in the literature.
These two examples were grouped together to form a
specific subaction of Conceptual Research Use: using
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standing of the health issue (subaction 1a; Figure 2).
Having identified the subactions of each research use
domain, the next step involved dividing each subaction
into its levels (Table 1). Levels in conjoint analysis refer
to the possible values of a subaction [50]. Hair et al. [50]
emphasised that levels should be stated in concrete terms.
As a result we separated the majority of subactions intoFigure 2 Subactions and levels for each research use domain.just two levels: (i) Yes, the action was performed or (ii) No,
the action was not performed. Only one subaction for in-
strumental use contained three levels, representing the
extent to which research influenced the decisions relating
to the policy document. Identifying the levels of subactions
was a necessary step before conducting the conjoint
analysis, so that profiles could be created. Profiles are com-
binations of subaction levels (Table 1 and Additional file 2).
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use domain is displayed in Figure 2.The experimental design
The full profile method was used [50], where each pro-
file consisted of one level from each subaction within a
particular research use domain. The profiles were hypo-
thetical, and presented in relation to policy and program
documents in general, rather than in relation to a spe-
cific policy document. Therefore, no documents or de-
scriptions of specific policy documents were presented.
The subactions and levels gave rise to a large number
of possible profiles, particularly for conceptual use.
The number of profiles was reduced to a manageable
number (i.e. eight profiles for conceptual and tactical,
six profiles for instrumental, and four profiles for im-
posed use) using an Orthogonal Main Effects Plan
(OMEP) in R software [64]. The OMEP generated a
series of orthogonal and balanced profiles for each of
the four conjoint analyses. This was appropriate be-
cause we were only interested in main effects (i.e. the
utility values assigned to each research use subaction
level) rather than interactions among subaction levels
[50]. The small number of profiles generated for each
research use domain would enhance the efficiency of
the task and reduce the cognitive load on our sample.
The complete list of profiles for all four research use
domains is displayed in Additional file 2.Eliciting preferences
In order to elicit respondents’ preferences, they were
instructed to rate the standard of each profile on the same
1 to 9 ordinal scale (Figure 3). Profiles were presented
using an online survey created using Survey Monkey
software [65]. Respondents completed four online surveys,
one for each research use domain. The survey order was
as follows: Instrumental use, Conceptual use, Tactical use,
and Imposed use.Figure 3 Example scenario for conceptual research use.All potential respondents were contacted by email,
where study information and a link to the online survey
were provided. The first page was an online consent
form. On the second page, respondents entered personal
details including their assigned ID number (which was
sent with their invitation email), affiliation, and current
working role, which they could select as either ‘policy-
maker’, ‘researcher’, ‘both’, or ‘other’. If ‘other’ was
chosen, they were required to specify their working role
in a textbox. After providing their details, respondents
completed the conjoint surveys for research use domain
(see [48] for details). Respondents were then presented
with the four conjoint surveys for each research use do-
main. Each survey with its corresponding profiles was
presented on a separate page. On each survey page, key
terms within profiles were hyperlinked to a glossary
page, which opened in a new browser tab when clicked.
The glossary provided definitions and concrete examples
of all the key terms including the four research use do-
mains and the subactions within each domain in order
to assist respondents in making their ratings of each
profile. See Figure 3 for an example scenario of concep-
tual research use that respondents rated. All respondents
were presented with the same set of profiles generated
from the OMEP. Respondents were required to rate on a
1 to 9 scale, whether the profile represented a limited
(1–3), moderate (4–6), or extensive (7–9) form of the re-
search use domain in question. The presentation order
of profiles was randomised across respondents. Respon-
dents were required to rate all profiles for a particular
research use domain before moving onto the next page.
Data analyses
Four conjoint analyses were undertaken using SPSS
GENLIN (using a logit link function and robust estima-
tor), which is appropriate when ratings are made on an
ordinal scale, predictors are categorical, and participants
provide multiple responses [66]. An exchangeable work-
ing correlation structure was used because examination
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ratings of profiles within subjects were correlated at
approximately similar magnitudes [67]. There were
problems with convergence due to singularity on one
conjoint analysis (i.e. conceptual use). Based on the
recommendations of Lipsitz et al. [68], estimates ob-
tained from the first iteration of the GENLIN proced-
ure were used for this research use domain.
Raw regression coefficients for each subaction level
were calculated, which represented the part-worth util-
ities of each subaction level. To make the part-worth
utilities meaningful, they were rescaled into a positive
value out of 9 using the guidelines provided by Hair
et al. [50]. Larger rescaled utility values indicated that
a particular subaction (level) was particularly influen-
tial in guiding respondents’ ratings. Importance values
were calculated using the guidelines of Hair et al. [50] to
quantify the relative importance of each subaction. Larger
part-worth utilities and importance values indicate that a
particular subaction was relatively more influential in
guiding respondents’ ratings.
SPSS CONJOINT was used to identify respondents
that exhibited reversals; that is, highly inconsistent re-
sponses and illogical patterns in preferences for particu-
lar subaction levels [50]. Hair et al. [50] proposed that
respondents who display many reversals are potential
candidates for deletion from the analyses.Results
In Table 3, we display the raw and rescaled part-worth
utilities for each research use subaction, as well as the
importance values for each subaction.Respondent characteristics
Out of the 361 participants invited, 54 respondents
(14.96%) consented and completed all four surveys.
These 54 respondents had earlier completed six other
surveys for the research engagement actions component
of SAGE [48]. Based on Orme’s [69] guidelines regarding
the appropriate sample size for investigational work and
developing hypotheses about a particular group (i.e. be-
tween 30 and 60), our sample size was sufficient.Table 2 Respondent characteristics
Working role





3 (5.6%) 8 (14.8%) 4 (7.4%)
Female Count
(% total)
10 (18.5%) 9 (16.7%) 10 (18.5%) 7
Total Count
(% total)
13 (24.1%) 17 (31.5%) 14 (25.9%) 10Respondent characteristics are displayed in Table 2
for the sample that completed all four surveys (N = 54).
There were significantly more female than male partici-
pants (χ2(1, N = 54) = 6, P = 0.01). There were no signifi-
cant differences relating to the working role of
participants (χ2(3, N = 54) = 1.85, P = 0.60), nor was there
a significant association between working role and sex
(χ2(3, N = 54) = 2.25, P = 0.52). There was a significant ef-
fect of geographic region, with most participants coming
from Australia, followed by North America (primarily
Canada, with one participant from the United States) and
then Europe (mainly the UK, with one participant from
Norway; χ2(2, N = 54) = 49.00, P <0.001). There was no
significant relationship between geographic region and sex
(χ2(2, N = 54) = 5.46, P = 0.07).
Conjoint analysis findings for each type of research use
Conceptual research use
One respondent exhibited six reversals and was elimi-
nated, leaving 53 respondents in the analyses. All raw
utility coefficients were highly significant and negative,
implying that each subaction was positively associated
with greater conceptual use. Based on the rescaled coef-
ficients and importance values, experts’ ratings of con-
ceptual research use were most strongly affected by
whether or not the policymaker could specify examples
of research that contributed to his/her understanding of
the issue (subaction 1g). In terms of the specific type of
conceptual understanding (subactions 1a–d), respon-
dents considered conceptual use to be greater when pol-
icymakers used research to improve their understanding
of alternative strategies to deal with the current health
problem (subaction 1d) and the policy context (subac-
tion 1b), relative to improving their background under-
standing of the issue (subaction 1a) or knowledge and
skills in applying research to policy (subaction 1c). Re-
spondents also gave higher ratings if policymakers could
describe examples of research that contributed to their
increased understanding (subaction 1e). Ratings of con-
ceptual research use were higher if research influenced
policymakers’ core, as opposed to their peripheral under-
standing of the health issue, although this subaction had
the lowest relative utility.Geographic region (Continent)
ther Total Australia North America Europe Total
3 (5.6%) 18 (33.3%) 11 (20.4%) 6 (11.1%) 1 (1.9%) 18 (33.3%)
(13.0%) 36 (66.7%) 31 (57.4%) 3 (5.6%) 2 (3.7%) 36 (66.7)%
(18.5%) 54 (100%) 42 (77.8%) 9 (16.7%) 3 (5.6%) 54 (100%)
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All 54 respondents were included in the analysis. Raw
utility coefficients were significant and negative for both
subactions, indicating that each was positively associated
with greater instrumental research use. Based on the
rescaled coefficients, respondents considered instrumen-
tal research use to be most extensive if research influ-
enced the core components of the decision or course of
action (as opposed to providing additional or vague de-
tails) and policymakers could identify the specific re-
search that influenced these decisions. Based on the
importance values, the subaction referring to the extent
of direct research use within the document (subaction
2a) was two times more important than whether or not
the policymaker specified examples of research that in-
fluenced the policy (subaction 2b).
Tactical research use
All 54 respondents were included in the analysis.
Each raw utility coefficient was significant and nega-
tive, implying that each of the four subactions was as-
sociated with higher tactical use ratings. Based on the
rescaled coefficients and importance values, the most
important subaction was using research to persuade
targeted stakeholders to support or act upon an existing
decision (subaction 3b), versus using research to justify a
decision (subaction 3a), or inform stakeholders about the
health issue (subaction 3d). The latter two subactions had
similar importance values. Using research to persuade per-
ipheral stakeholders (subaction 3c) had the lowest rescaled
utility, and its importance was almost half that of subac-
tion 3b (i.e. persuading targeted stakeholders).
Imposed research use
One respondent exhibited reversals on all subactions
and was eliminated, leaving 53 respondents in the ana-
lysis. Raw utility coefficients for each subaction were sig-
nificant and negative indicating that each was associated
with more extensive imposed research use. Examining
the rescaled coefficients and importance values, respon-
dents’ ratings for imposed use were most strongly influ-
enced by whether organisations mandated research use
(subaction 4a) relative to if they expected (subaction 4b)
or encouraged research use (subaction 4c). Furthermore,
ratings of imposed use were greater if organisations ex-
pected (subaction 4b), rather than encouraged (subac-
tion 4c) research use.
Using the scoring system
The utilities in Table 3 provided the basis for scoring each
research use domain in SAGE. Utilities were rescaled so
that they summed to nine within each research use do-
main. This was done because each research use domain is
scored on a scale of 1 to 9 in SAGE (where 1–3 = limited;4–6 = moderate, and 7–9 = extensive). Thus, the rescaled
utility is the score assigned to each research use subaction
in the scoring tool. Using policymakers’ responses to the
SAGE interview and the accompanying policy document,
if a policymaker had engaged in a particular subaction, it
is ticked off and the utility score is assigned for that
subaction.
Using conceptual research use as an example, if it
was evident that research increased the policymakers’
core understanding (utility = 0.88) of background as-
pects of the health issue (utility = 1.19) and the pol-
icy context (utility = 1.41), and he/she cited specific
examples of research (utility = 2.81), he/she would be
assigned a score of 0.88 + 1.19 + 1.41 + 2.81 = 6.29
(out of 9), which would represent moderate concep-
tual research use (Figure 4). The full scoring tool is
provided in Additional file 3.
Discussion
We have used conjoint analysis with a sample of experts
with experience in health policy and research to develop
the first empirically derived system of scoring research
use in policy development. Conjoint analysis provided a
systematic and innovative method of quantifying the
relative importance of subactions for each research use
domain measured in SAGE. To our knowledge, the
current study represents the first attempt to numerically
quantify the relative importance of different research use
subactions. The consistency of the present findings to
previous qualitative research points to the face validity
and appropriateness of our scoring system.
Summary and exploration of findings in relation to
previous research
Beginning with conceptual use, the subaction with the
greatest importance was whether policymakers could
specify examples of research that contributed to their
understanding of the policy issue (subaction 1f). This
finding is in contrast with previously published views of
knowledge translation researchers and the findings of
qualitative research conducted among health decision
makers, which suggest that conceptual research use is
often an indirect, diffuse, and gradual process by which
research shapes ideas and beliefs that subsequently influ-
ence policy [19,46,70-72]. Our results suggest that ex-
perts regard the ability to retrieve specific research as
representing a stronger form of conceptual use.
In terms of specific types of conceptual understanding,
the subaction with the greatest importance to conceptual
use was whether research increased understanding of al-
ternative strategies and perspectives to deal with the
health issue (subaction 1d). In a number of qualitative
interview studies, policymakers have stated that they pri-
marily use research to identify new approaches to deal
Table 3 Research use domains, subactions, subaction levels, raw utilities, standard errors, and rescaled utility coefficients
for each domain








1. Conceptual research use a. Background understanding
of the health issue
i. No −0.92 (0.15) 0 11.47
ii. Yes 0 1.19
b. Understanding of
the policy context
i. No −1.09 (0.14) 0 16.27
ii. Yes 0 1.41
c. Value, skills, and/or
understanding of
research use in policy
i. No −0.84 (0.16) 0 9.82
ii. Yes 0 1.09
d. Alternative perspectives
and/or strategies
i. No −1.26 (0.14) 0 18.94
ii. Yes 0 1.62
e. Informed core
understanding of the issue
i. No, just clarified −0.69 (0.12) 0 9.43
ii. Yes 0 0.88
f. Examples were specified i. No −2.18 (0.23) 0 34.07
ii. Yes 0 2.81
2. Instrumental research use a. Research informed the
core of the decision
No/negligible influence −4.34 (0.50) 0 69.37
ii. No, additional details
only
−2.37 (0.33) 2.15
iii. Yes 0 4.75
b. Examples were specified i. No −1.92 (0.27) 0 30.63
ii. Yes 0 2.10
3. Tactical research use a. Support, confirm, or justify
predetermined decisions
i. No −1.44 (0.19) 0 24.59
ii. Yes 0 2.21
b. Persuade targeted
stakeholders
i. No −1.88 (0.22) 0 32.25
ii. Yes 0 2.90
c. Persuade peripheral
stakeholders
i. No −1.10 (0.15) 0 18.89
ii. Yes 0 1.70
d. Inform stakeholders
about key issues
i. No −1.42 (0.18) 0 24.26
ii. Yes 0 2.18
4. Imposed research use a. Organisation mandates
research use
i. No −3.37 (0.60) 0 43.69
ii. Yes 0 3.93
b. Organisation expects
research use
i. No −2.64 (0.44) 0 34.31
ii. Yes 0 3.09
c. Organisation encourages
research use
i. No −1.70 (0.39) 0 22.00
ii. Yes 0 1.98
aAll P <0.001 (using Wald χ2 statistics).
bUtility coefficients were rescaled so that they are positive, that the lowest level of each subaction has a zero-coefficient, and add up to 9.
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advantages and disadvantages of these options. It is this
knowledge that eventually informs the content and dir-
ection of future policies. The next highest subaction was
where research increased understanding of the policy
context (e.g. the target population, neglected issues, pri-
orities and needs, targets for future action; subaction
1b). Indeed, numerous qualitative interview studies with
decision makers in a range of health areas suggest that
research is used often by policymakers to gain a greaterunderstanding of the characteristics, needs, and prefer-
ences of potential service users [3,70], broader policy is-
sues [70], neglected health issues, and important targets
for future action [43,72].
For instrumental use, the subaction with the greatest
importance was the extent to which research directly in-
fluenced the policy document’s content. From the
rescaled utilities, ratings of instrumental use were most
influenced by whether policymakers used research to
directly inform the core components of a decision, view,
Figure 4 Scoring tool for conceptual research use.
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subaction level was more than double that of using re-
search to provide additional details to inform a decision
or course of action (subaction 2a.ii). This result is unsur-
prising given that previous studies examining research
use among health decision makers indicate that true in-
strumental use is where research has direct and concrete
impacts on the formulation, implementation, and evalu-
ation of policies, programs, and services [5,19,46,74], ra-
ther than just refining or supplementing predetermined
decisions [43]. Lavis et al. [5] also described that instru-
mental research use occurs when policy documents ex-
plicitly cite research. Our findings agree with this, as the
utility for subaction 2b (i.e. the policymaker clearly
specified examples of research that contributed to the
decision) had a significant and non-trivial impact on re-
spondents’ ratings of instrumental use.
For tactical use, the subaction with the greatest import-
ance was where research was used to provide evidence to
influence targeted (as opposed to peripheral) stakeholders
to support or act upon an established decision or view
(subaction 3b). In support of these findings, evidence sug-
gests that the primary tactical use of research is to provide
ammunition for a decision or course of action so that
stakeholders will support the existing decision [47,75],
provide funding for the decision [3,43], contribute to the
implementation of policies [16,76], or delay making deci-
sions on particular issues [47]. Furthermore, research by
El-Jardali et al. [7] indicated that, in developing countries,
gaining stakeholder support is essential to improving the
general climate towards research use among policymakersand enabling evidence-informed policy initiatives. It is well
known that policymaking is highly influenced by a range
of stakeholders, particularly those with power and political
influence [76]. Therefore, it is not unusual that attempting
to persuade stakeholders’ beliefs and actions through re-
search emerged as the most important subaction of tac-
tical use.
Using research to back up a predetermined action
(subaction 3a) emerged as the next most important
subaction of tactical use. This aligns with previous
qualitative research demonstrating that policymakers
often report using research as a form of reassurance to
justify or confirm a predetermined decision to oneself
and others [43]. Using research to inform stakeholders
about the current status of the problem (subaction 4)
obtained a similar importance value. Policymakers have
reported using research to inform stakeholders about
key aspects of health issues such as background details
(e.g. rates, nature or complexity, medical, or technical
issues) [3,43], neglected areas of need [43], alternative
options, preferences of users [70], and priorities for
future action [72]. It is interesting, however, that merely
informing stakeholders emerged as a comparably im-
portant subaction of tactical use for our respondents.
Respondents may have perceived that using research to
inform stakeholders about a particular health issue will
likely encourage them to support and act upon policies
relating to that issue.
Finally, respondents’ ratings of imposed research use
were most strongly influenced by organisations mandating
(subaction 4a), as opposed to expecting (subaction 4b) or
Makkar et al. Health Research Policy and Systems  (2015) 13:35 Page 12 of 15encouraging (subaction 4c), research use among staff. In-
deed, previous research suggests that when organisations
impose research use, they formally require or mandate
staff to use research in policy by implementing strict pol-
icymaking guidelines, have compulsory knowledge transla-
tion programs and workshops, and apply performance
management systems that incorporate research use and
skills in retention and promotion decisions [77-80].
Advantages of SAGE
In the introduction, we summarised the numerous bene-
fits of developing measures of research use, and the limi-
tations of previous measures. SAGE has been developed
to overcome many of these limitations [9,36]. For ex-
ample, SAGE is strongly based on a theoretical model,
the SPIRIT Action Framework [28], and comprehen-
sively assesses the different ways that research can be
used in the development of a specific policy document.
Another key advantage of SAGE is that it incorporates
the combination of a structured, qualitative interview and
analysis of a corresponding policy document. The policy
document can be used to identify explicit references to re-
search, thus providing an objective means of assessing in-
strumental research use. Interviews, on the other hand,
can unravel the broad application of research in policy de-
velopment such as the more diffuse forms of research use
(e.g. conceptual, tactical), the influence of research on
agenda-setting or other priority setting exercises sur-
rounding the policy [45], the contextual factors, capacity,
barriers, and facilitators underlying research use, and the
research engagement actions undertaken to obtain re-
search. As a result, interviews can help to unravel the
complex ways policymakers use research to inform policy
or program development [81]. The use of a combination
of measures provides an integrated, holistic, and valid ap-
proach to assessing research use in health policy [9].
The scoring system described in the current paper is
one of the major advantages of SAGE over previous
measures of research use in a discrete policy document
(e.g. [37]). Not only have we developed a measure that
separates each research use domain into its key subac-
tions, but we have used conjoint analysis for the first
time to calculate utilities and scores that quantify the rela-
tive importance of different research use subactions, based
on the opinions and preferences of experts in health policy
and research.
We considered using qualitative methods of obtaining
expert opinion such as verification and Delphi panels
[82-85]. However, these approaches do not provide a
systematic means of assigning numeric scores to individ-
ual subactions. Conjoint analysis, on the other hand,
provides a systematic statistical method of assigning util-
ities (i.e. scores) to each subaction, thus enabling the cal-
culation of total scores for each research use domain.Because of these advantages, conjoint analysis was used
in the present study.
Obtaining these utilities and importance values has
two primary advantages. Firstly, it allows SAGE users to
calculate appropriate, face-valid scores for each research
use domain. Secondly, policy organisations using SAGE
can identify the most important components of each re-
search use domain, and use this information to invest in
capacity-building interventions to improve subsequent
research use. For example, the most important conceptual
research use subaction (besides retrieving specific exam-
ples of research) was whether research informed policy-
makers’ understanding of alternative perspectives and
strategies to deal with the health issue. Such conceptual
understanding is important, as it may encourage policy-
makers to question assumptions and current practices,
generate alternative strategies and recommendations, and
influence what courses of action should or should not be
adopted [43]. Using this information, policy organisations
can encourage policymakers to focus on the actionable
components of research, and to invest in programs and re-
sources to help staff use research effectively so they can
identify and comprehend alternative strategies, and adapt
these to the current policy context [22,80]. SAGE can then
be used to assess whether or not these capacity building
interventions were effective in improving research use in
policy. Along these lines, SAGE is currently being used as
the main outcome measure in SPIRIT, a longitudinal study
examining the impact of a multifaceted program on the
capacity of health organisations to use research in the de-
velopment of policies and programs (see [86] for details).
Limitations, theoretical issues, and ideas for future
research
It is possible that the subactions included in the con-
joint analysis (and thus, in the scoring tool) did not
capture the complete breadth of each research use
domain. However, given that we conducted extensive
qualitative analyses of over 65 interviews with policy-
makers and extensively reviewed previous literature
on evidence-informed health policymaking, we are
confident that the main components of each research
use domain were included.
Although the SAGE scoring tool quantifies multiple
subactions of research use, it does not quantify in-depth
issues such as why research was used and the context in
which it is used. Importantly, however, these aspects are
addressed in the SAGE interview (Additional file 1). We
believe that these aspects should be explored qualitatively
due to their complexity. These qualitative details can be
used to contextualise and add explanatory understanding
to the scores obtained with the SAGE scoring tool.
The number of subactions for each research use do-
main did not exceed six. We did this to ensure the
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ever, we must note that participants had already com-
pleted six other conjoint surveys [48] by the time they
reached the first research use survey. Therefore, there is
a possibility that they may have been mentally fatigued
while doing the research use surveys, thereby reducing
their ability to discriminate between profiles [50]. How-
ever, we are reassured by the fact that the relative im-
portance of each research use subaction was, for the
most part, consistent with previous research. Further-
more, only one respondent exhibited reversals in two of
the surveys, and no respondents gave identical ratings
for all profiles. This suggests that our sample was en-
gaged and were able to discriminate between profiles,
thus supporting the validity of our findings.
There are limitations relating to the interview-based
nature of SAGE. For example, the interview only targets
aspects of research use that policymakers can consciously
retrieve. Qualitative research among mental health deci-
sion makers indicates that research can also shape policy
makers’ understanding of policy issues gradually, indir-
ectly, and unconsciously [40,46]. These unconscious
(conceptual) aspects of research use are not directly mea-
sured in SAGE, although arguably such measurement
would be very hard to do so in practice. Oliver et al. [87]
have also argued that interviews often impose a dichotomy
between research and policymaking and thus do not
accurately reflect how policymakers use research in prac-
tice. Instead, they claim that observational studies provide
a more valid method of evaluating policymakers’ use of re-
search, and that such research is lacking. Although SAGE
is interview-based, it goes some way towards addressing
these issues by incorporating analysis of an actual policy
document. We agree that direct observation of policy-
makers would provide the most effective way of assessing
policymakers’ use of research, but there are likely to be
significant feasibility issues due to the probable inconveni-
ence to policy agencies of having an observer, as well as is-
sues relating to privacy and confidentiality.
The sample size for our study was relatively small
compared to other conjoint analysis studies and sample
size recommendations [69,88]. However, large sample
sizes are only possible if the target population is large
[69, 88], which is not the case here. Orme [69] recom-
mended that for investigational work and developing hy-
potheses about a particular group, 30 to 60 respondents
may be sufficient, and our findings are consistent with
these guidelines. Nevertheless, future studies may benefit
from employing a larger sample size in order to verify
the reliability of the utilities and importance values ob-
tained in the present study. Future research must also
incorporate a more ethnically diverse sample, including
experts from developing countries, as they may have dif-
ferent perspectives regarding the relative importance ofeach research use subaction. Until such research is
undertaken, it is uncertain as to whether the scoring tool
can be used to assess research use in developing
countries.
A final key issue relates to the generalisability of the
SAGE scoring tool. Specifically, the utilities (scores) ob-
tained from the conjoint analysis represent the relative
importance of subactions in the context of policymaking
in general. It is possible that these utilities do not apply
to all kinds of policies (e.g., treatment guidelines, models
of care, service delivery arrangements), and that different
utilities would have emerged if a particular policy type
or issue was specified. Further validity testing of SAGE
is required to determine whether it can be used to meas-
ure research use across a broad range of policies and
contexts.
Conclusions
In this study, we have used conjoint analysis to develop
an innovative system to score four types of research use
in policy development. The scoring system is based on
experts’ opinions regarding which subactions are most
representative of each type of research use. This novel
method has allowed us to establish a context-sensitive
scoring system that will allow policy organisations to ef-
fectively quantify their level of research use, help them
determine the critical components of each research use
domain, and trigger investment in programs and re-
sources to improve subsequent research use capacity
within the organisation.
Endnote
1In a typical conjoint analysis, subactions would be re-
ferred to as attributes [56]; however, we used the term sub-
actions to enhance clarity, comprehension, and consistency
of terms throughout this paper.
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